A 1 TYR 19 -14.865 -15.341
A 2 GLU 5 -16.433 -15.118
A 3 THR 29 -17.715 -19.013
A 4 PHE 8 -18.104 -16.942
A 5 VAL 39 -18.462 -20.824
A 6 CYS 12 -16.911 -16.346
A 7 GLU 12 -13.287 -13.139
A 8 LYS 5 -11.476 -10.731
A 9 ALA 28 -14.263 -15.842
A 10 LYS 1 -11.327 -10.139
A 11 ALA 4 -10.357 -9.626
A 12 ASP 0 -11.134 -9.854
A 13 GLN 19 -13.636 -14.253
A 14 LEU 9 -15.223 -14.507
A 15 ILE 33 -17.287 -19.094
A 16 GLN 27 -16.177 -17.421
A 17 THR 7 -13.399 -12.663
A 18 LEU 34 -12.174 -14.684
A 19 HIS 3 -7.472 -6.958
A 20 ALA 31 -5.582 -8.505
A 21 VAL 3 -1.775 -1.916 <=B
A 22 ASP 20 1.418 -1.045 <=B
A 23 LYS 0 2.658 2.352 <=B
A 24 ASP 7 3.782 2.542 <=B
A 25 ASP 0 4.740 4.195 <=B
A 26 PRO 11 4.936 3.104 <=B
A 27 TYR 1 5.321 4.594 <=B
A 28 SER 5 5.008 3.857 <=B
A 29 GLY 5 4.538 3.442 <=B
A 30 HIS 19 3.423 0.844 <=B
A 31 GLN 10 1.223 -0.068 <=B
A 32 PHE 26 -3.157 -5.784
A 33 SER 11 -4.823 -5.533
A 34 PHE 26 -8.587 -10.589
A 35 SER 12 -10.748 -10.892
A 36 LEU 22 -13.523 -14.498
A 37 ALA 14 -12.030 -12.256
A 38 PRO 3 -9.584 -8.827
A 39 GLU 8 -11.767 -11.334
A 40 ALA 22 -13.454 -14.437
A 41 ALA 9 -11.817 -11.493
A 42 SER 2 -9.211 -8.382
A 43 GLY 2 -9.731 -8.842
A 44 SER 26 -13.779 -15.184
A 45 ASN 28 -13.432 -15.107
A 46 PHE 38 -15.399 -17.998
A 47 THR 14 -14.352 -14.312
A 48 ILE 33 -13.148 -15.431
A 49 GLN 14 -10.090 -10.540
A 50 ASP 16 -6.732 -7.798
A 51 ASN 13 -5.064 -5.977
A 52 LYS 0 -2.104 -1.862 <=B
A 53 ASP 3 -1.149 -1.362 <=B
A 54 ASN 11 -3.277 -4.165
A 55 THR 8 -6.228 -6.432
A 56 ALA 27 -10.028 -11.980
A 57 GLY 12 -13.458 -13.290
A 58 ILE 33 -15.689 -17.680
A 59 LEU 15 -15.497 -15.440
A 60 THR 23 -14.496 -15.474
A 61 ARG 14 -11.294 -11.606
A 62 LYS 11 -10.339 -10.415
A 63 ASN 0 -9.665 -8.553
A 64 GLY 2 -10.561 -9.576
A 65 TYR 28 -12.423 -14.215
A 66 ASN 2 -9.278 -8.441
A 67 ARG 11 -10.007 -10.121
A 68 HIS 0 -6.555 -5.801
A 69 GLU 8 -6.620 -6.778
A 70 MET 15 -9.867 -10.457
A 71 SER 4 -12.266 -11.315
A 72 THR 7 -14.489 -13.627
A 73 TYR 36 -16.018 -18.316
A 74 LEU 7 -16.703 -15.587
A 75 LEU 36 -17.362 -19.505
A 76 PRO 10 -14.627 -14.095
A 77 VAL 32 -14.444 -16.463
A 78 VAL 13 -9.916 -10.270
A 79 ILE 21 -7.323 -8.896
A 80 SER 15 -5.120 -6.256
A 81 ASP 14 -0.144 -1.737 <=B
A 82 ASN 16 1.955 -0.110 <=B
A 83 ASP 13 2.898 1.070 <=B
A 84 TYR 0 2.536 2.245 <=B
A 85 PRO 3 2.257 1.652 <=B
A 86 VAL 12 0.141 -1.255 <=B
A 87 GLN 5 -1.083 -1.533 <=B
A 88 SER 15 -4.502 -5.709
A 89 SER 11 -6.512 -7.028
A 90 THR 10 -10.081 -10.072
A 91 GLY 19 -11.331 -12.213
A 92 THR 7 -15.167 -14.228
A 93 VAL 31 -16.996 -18.606
A 94 THR 7 -17.552 -16.338
A 95 VAL 34 -18.180 -19.999
A 96 ARG 5 -16.569 -15.238
A 97 VAL 19 -15.713 -16.091
A 98 CYS 12 -15.264 -14.889
A 99 ALA 4 -13.660 -12.549
A 100 CYS 14 -13.959 -13.963
A 101 PRO 6 -11.850 -11.177
A 102 LEU 4 -11.060 -10.249
A 103 GLU 5 -10.444 -9.818
A 104 VAL 1 -9.543 -8.561
A 105 LEU 1 -7.746 -6.970
A 106 PHE 0 -5.927 -5.245
A 107 GLN 0 -3.672 -3.250 <=B

Identified 21 B-Cell epitope residues out of 107 total residues